The heart in Duchenne muscular dystrophy: Early detection of contractile performance alteration

Journal of Cellular and Molecular Medicine

Volumn 16, Issue 12, 2012, Pages 3028-3036

  Wagner, Sören ^a,b,c   Knipp, Stephan ^b   Weber, Cornelia ^a   Hein, Selina ^a   Schinkel, Stefanie ^a   Walther, Andreas ^a   Bekeredjian, Raffi ^a   Müller, Oliver J ^a   Friedrich, Oliver ^a,d  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

^c UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^d UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Calcium; Force transients; Motility assay; Muscular dystrophy; Papillary muscle

Indexed keywords

CALCIUM;

ANIMAL; ARTICLE; CARDIOMEGALY; CARDIOMYOPATHY; CELL CULTURE; CYTOLOGY; DUCHENNE MUSCULAR DYSTROPHY; ECHOCARDIOGRAPHY; HEART; HEART CONTRACTION; HEART MUSCLE; HEART PAPILLARY MUSCLE; METABOLISM; MOUSE; PATHOPHYSIOLOGY; X CHROMOSOME LINKED MUSCULAR DYSTROPHIC MOUSE;

ANIMALS; CALCIUM; CARDIOMEGALY; CARDIOMYOPATHIES; CELLS, CULTURED; ECHOCARDIOGRAPHY; HEART; MICE; MICE, INBRED MDX; MUSCULAR DYSTROPHY, DUCHENNE; MYOCARDIAL CONTRACTION; MYOCARDIUM; PAPILLARY MUSCLES;

MUS;

EID: 84871096228     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2012.01630.x     Document Type: Article

References (40)

1. Finsterer J, Stöllberger C. The heart in human dystrophinopathies. Cardiology. 2003; 99: 1-19.
2. Williams IA, Allen DG. Intracellular calcium handling in ventricular myocytes from mdx mice. Am J Physiol Heart Circ Physiol. 2007; 292: H846-55.
3. Quinlan JG, Hahn HS, Wong BL, et al. Evolution of the mdx mouse cardiomyopathy: physiological and morphological findings. Neuromusc Disord. 2004; 14: 491-6.
4. Merrick D, Stadler LKJ, Larner D, et al. Muscular dystrophy begins early in embryonic development deriving from stem cell loss and disrupted skeletal muscle formation. Dis Model Mech. 2009; 2: 374-88.
5. Tanabe Y, Esaki K, Nomura T. Skeletal muscle pathology in X-chromosome-linked muscular dystrophy (mdx) mouse. Acta Neuropathol. 1986; 69: 91-5.
6. Pastoret C, Sebille A. Further aspects of muscular dystrophy in mdx mice. Neuromusc Disord. 1993; 3: 471-5.
7. 2+ influx into dystrophic mdx cardiomyocytes. Cell Calcium. 2009; 46: 114-21.
8. Janssen PML, Hiranandani N, Mays TA, et al. Utrophin deficiency worsens cardiac contractile dysfunction present in dystrophin-deficient mdx mice. Am J Physiol Heart Circ Physiol. 2005; 289: H2373-8.
9. Sapp JL, Bobet J, Howlett SE. Contractile properties of myocardium are altered in dystrophin-deficient mdx mice. J Neurol Sci. 1996; 142: 17-24.
10. Widen C, Barclay CJ. Resting metabolism of mouse papillary muscle. Pflugers Arch. 2005; 450: 209-16.
11. 2 supply to isolated preparations of mammalian skeletal and cardiac muscle. J Muscle Res Cell Motil. 2005; 26: 225-35.
12. Gailly P, Boland B, Himpens B, et al. Critical evaluation of cytosolic calcium determination in resting muscle fibres from normal and dystrophic (mdx) mice. Cell Calcium. 1993; 14: 473-83.
13. Svensson C, Morano I, Arner A. In vitro motility assay of atrial and ventricular myosin from pig. J Cell Biochem. 1997; 67: 241-7.
14. Friedrich O, Both M, Weber C, et al. Microarchitecture is severely compromised but motor protein function is preserved in dystrophic mdx skeletal muscle. Biophys J. 2010; 98: 606-16.
15. Friedrich O, Weber C, v Wegner F, et al. Unloaded speed of shortening in voltage-clamped skeletal muscle fibers from wt, mdx and transgenic minidystrophin mice using a novel high-speed acquisition system. Biophys J. 2008; 94: 4751-65.
16. Goehringer C, Rutschow D, Bauer R, et al. Prevention of cardiomyopathy in δ-sarcoglycan knockout mice after systemic transfer of targeted adeno-associated viral vectors. Cardiovasc Res. 2009; 82: 404-10.
17. Andruchov O, Andruchova O, Galler S. Fine-tuning of cross-bridge kinetics in cardiac muscle of rat and mouse by myosin light chain isoforms. Pflugers Arch. 2006; 452: 667-73.
18. Williams IA, Allen DG. The role of reactive oxygen species in the hearts of dystrophin-deficient mdx mice. Am J Physiol Heart Circ Physiol. 2007; 293: H1969-77.
19. Fouconnier J, Thireau J, Reiken S, et al. Leaky RyR2 trigger ventricular arrhythmias in Duchenne muscular dystrophy. Proc Natl Acad Sci USA. 2010; 107: 1559-64.
20. Xu Y, Delfin DA, Rafael-Fortney JA, et al. Lengthening-contractions in isolated myocardium impact force development and worsen cardiac contractile function in the mdx mouse model of muscular dystrophy. J Appl Physiol. 2011; 110: 512-9.
21. Endoh M. Force-frequency relationship in intact mammalian ventricular myocardium: physiological and pathophysiological relevance. Eur J Pharmacol. 2004; 500: 73-86.
22. Moerner SE, Wohlfahrt B. Myocardial force interval relationships: influence of external sodium and calcium, muscle length, muscle diameter and stimulation frequency. Acta Physiol Scand. 1992; 145: 323-32.
23. Ross J Jr, Miura T, Kambayashi M, et al. Adrenergic control of the force-frequency relation. Circulation. 1995; 92: 2327-32.
24. 2+ current to myocardial contractility. Can J Physiol Pharmacol. 2009; 87: 69-75.
25. Redel A, Baumgartner W, Golenhofen K, et al. Mechanical activity and force-frequency relationship of isolated mouse papillary muscle: effects of extracellular calcium concentration, temperature and contraction type. Pflugers Arch. 2002; 445: 297-304.
26. Bluhm WF, Kranias EG, Dillmann WH, et al. Phospholamban: a major determinant of the cardiac force-frequency relationship. Am J Physiol. 2000; 278: H245-55.
27. Meyer M, Bluhm WF, He H, et al. Phospholamban-to-SERCA2 ratio controls the force-frequency relationship. Am J Physiol Heart Circ Physiol. 1999; 276: H779-85.
28. 2+ binding proteins calsequestrin and sarcalumenin in dystrophin-deficient cardiac muscle. Biochim Biophys Acta. 2004; 1689: 252-8.
29. Hopf FW, Turner PR, Denetclaw WF, et al. A critical evaluation of resting intracellular free calcium regulation in dystrophic mdx muscle. Am J Physiol Cell Physiol. 1996; 40: C1325-39.
30. Dong Gao W, Perez NG, Marban E. Calcium cycling and contractile activation in intact mouse cardiac muscle. J Physiol. 1998; 507: 175-84.
31. Röder IV, Lissandron V, Martin J, et al. PKA microdomain organisation and cAMP handling in healthy and dystrophic muscle in vivo. Cell Signal. 2009; 21: 819-26.
32. Sarma S, Li N, van Oort RJ, et al. Genetic inhibition of PKA phosphorylation of RyR2 prevents dystrophic cardiomyopathy. Proc Natl Acad Sci USA. 2010; 107: 13165-70.
33. Verduyn SC, Zaremba R, van der Velden J, et al. Effects of contractile protein phosphorylation on force development in permeabilized rat cardiac myocytes. Basic Res Cardiol. 2007; 102: 476-87.
34. Colson BA, Locher MR, Bekyarova T, et al. Differential roles of regulatory light chain and myosin binding protein-C phosphorylations in the modulation of cardiac force development. J Physiol. 2010; 588: 981-93.
35. Song W, Dyer E, Stuckey D, et al. Investigation of a transgenic mouse model of familial dilated cardiomyopathy. J Mol Cell Cardiol. 2010; 49: 380-9.
36. Malmqvist UP, Aronshtam A, Lowey S. Cardiac myosin isoforms from different species have unique enzymatic and mechanical properties. Biochemistry. 2004; 43: 15058-65.
37. Coirault C, Lambert F, Poruny JC, et al. Velocity of actomyosin sliding in vitro is reduced in dystrophic mouse diaphragm. Am J Respir Crit Care Med. 2002; 165: 250-3.
38. Jearawiriyapaisarn N, Moulton HM, Kole R, et al. Long-term improvement in mdx cardiomyopathy after therapy with peptide-conjugated morpholino oligomers. Cardiovasc Res. 2010; 85: 444-53.
39. Schade van Westrum SM, Hoogerwaard EM, Dekker L, et al. Cardiac abnormalities in a follow-up study on carriers of Duchenne and Becker muscular dystrophy. Neurology. 2011; 77: 62-6.
40. Liao Y, Ihsikura F, Beppu S, et al. Echocardiographic assessment of LV hypertrophy and function in aortic-banded mice: necropsy validation. Am J Physiol Heart Circ Physiol. 2001; 282: H1703-8.